GlassScriptPhysician profile
Kien T Tran
NPI 1417158833
$2,227.20
in general payments reported to CMS, 2019-2025
19 companies · $569 in 2025
The $569 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $22.44 · 2022: $394 · 2023: $497 · 2024: $604 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,570 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,569.81 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $342.25 | 2022-2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $200.95 | 2022-2025 | Sotyktu |
| Lilly USA, LLC | $193.60 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Leo Pharma INC. | $188.73 | 2022-2025 | Adbry, Anzupgo |
| Amgen INC. | $166.78 | 2022-2024 | Otezla |
| Genzyme Corporation | $161.32 | 2022-2025 | |
| Arcutis Biotherapeutics, INC. | $149.35 | 2023-2025 | Zoryve |
| Celgene Corporation | $140.78 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $127.53 | 2023-2025 | Dupixent, Libtayo |
| Mayne Pharma Commercial LLC | $125.51 | 2022-2024 | |
| Dermavant Sciences, INC. | $101.30 | 2023-2024 | Vtama |
| Galderma Laboratories, L.P. | $69.56 | 2023-2025 | Aklief, Nemluvio |
| Novartis Pharmaceuticals Corporation | $66.80 | 2023-2024 | |
| Ucb, INC. | $56.93 | 2025 | Bimzelx |
| Abbvie INC. | $47.22 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $28.18 | 2025 | Opzelura |
| Epi Health, LLC | $22.44 | 2020 | |
| Organon LLC | $21.38 | 2025 | Vtama |
| Almirall LLC | $16.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kien Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.